Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichiro Nomata

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Urology|June 1, 2005
Decreased cellular membrane expression of gap junctional protein, connexin 43, in rat detrusor muscle with chronic partial bladder outlet obstructionKen-Ichi Mori, Mitsuru Noguchi, Manabu Matsuo, et al.
Virchows Archiv : an International Journal of Pathology|April 13, 2006
Pathological function of prostaglandin E2 receptors in transitional cell carcinoma of the upper urinary tractYasuyoshi Miyata, Kojiro Ohba, Shigeru Kanda, et al.
The Journal of Urology|June 7, 2006
Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosisYasuyoshi Miyata, Shigeru Kanda, Kojiro Ohba, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2012
Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysisYasuyoshi Miyata, Koichiro Nomata, Kojiro Ohba, et al.
Anticancer Research|March 2, 2005
The preventive effect of green tea on the gap junction intercellular communication in renal epithelial cells treated with a renal carcinogenHajime Takahashi, Koichiro Nomata, Ken-Ichi Mori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 29, 2004
Mucinous adenocarcinoma of the renal pelvis associated with transitional cell carcinoma in the renal pelvis and the bladderKousuke Takehara, Koichiro Nomata, Jiro Eguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 31, 2002
[Feasibility and change in the level of blood paclitaxel concentration after paclitaxel therapy for a hemodialysis patient with cisplatin resistant metastatic transitional cell cancer]Koichiro Nomata, Yuzi Sagara, Syohhei Toubu, et al.
International Journal of Clinical Oncology|November 10, 2011
Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III renal cell carcinomaShiro Hinotsu, Koji Kawai, Seiichiro Ozono, et al.
Urology|June 9, 2004
Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tractYasushi Hayashida, Koichiro Nomata, Mitsuru Noguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -DYasuyoshi Miyata, Shigeru Kanda, Kojiro Ohba, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Urology|June 1, 2005
Decreased cellular membrane expression of gap junctional protein, connexin 43, in rat detrusor muscle with chronic partial bladder outlet obstructionKen-Ichi Mori, Mitsuru Noguchi, Manabu Matsuo, et al.
Virchows Archiv : an International Journal of Pathology|April 13, 2006
Pathological function of prostaglandin E2 receptors in transitional cell carcinoma of the upper urinary tractYasuyoshi Miyata, Kojiro Ohba, Shigeru Kanda, et al.
The Journal of Urology|June 7, 2006
Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosisYasuyoshi Miyata, Shigeru Kanda, Kojiro Ohba, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2012
Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysisYasuyoshi Miyata, Koichiro Nomata, Kojiro Ohba, et al.
Anticancer Research|March 2, 2005
The preventive effect of green tea on the gap junction intercellular communication in renal epithelial cells treated with a renal carcinogenHajime Takahashi, Koichiro Nomata, Ken-Ichi Mori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 29, 2004
Mucinous adenocarcinoma of the renal pelvis associated with transitional cell carcinoma in the renal pelvis and the bladderKousuke Takehara, Koichiro Nomata, Jiro Eguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 31, 2002
[Feasibility and change in the level of blood paclitaxel concentration after paclitaxel therapy for a hemodialysis patient with cisplatin resistant metastatic transitional cell cancer]Koichiro Nomata, Yuzi Sagara, Syohhei Toubu, et al.
International Journal of Clinical Oncology|November 10, 2011
Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III renal cell carcinomaShiro Hinotsu, Koji Kawai, Seiichiro Ozono, et al.
Urology|June 9, 2004
Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tractYasushi Hayashida, Koichiro Nomata, Mitsuru Noguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -DYasuyoshi Miyata, Shigeru Kanda, Kojiro Ohba, et al.
Pageof 3